Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CKD Anemia in Dialysis Participants”

49 trials

Showing 20 of 49 results

Testing effectiveness (Phase 2)Study completedNCT00434330
What this trial is testing

Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 91
Testing effectiveness (Phase 2)Ended earlyNCT00372489
What this trial is testing

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Affymax 81
Not applicableStudy completedNCT02567188
What this trial is testing

MIRCERA in Participants With Chronic Kidney Disease Stage 3-4 and Not on Dialysis

Who this might be right for
Anemia
Hoffmann-La Roche 144
Testing effectiveness (Phase 2)Ended earlyNCT03446612
What this trial is testing

Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF)

Who this might be right for
Anaemia
GlaxoSmithKline 6
Testing effectiveness (Phase 2)Study completedNCT02260193
What this trial is testing

16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis

Who this might be right for
AnemiaEnd Stage Renal Disease
Akebia Therapeutics 94
Large-scale testing (Phase 3)Study completedNCT02273726
What this trial is testing

Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable Dialysis

Who this might be right for
CKD Anemia in Stable Dialysis Patients
Kyntra Bio 741
Early research (Phase 1)Study completedNCT05745883
What this trial is testing

Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia

Who this might be right for
Chronic Kidney DiseasesAnemia of Chronic Kidney Disease
Disc Medicine, Inc 55
Testing effectiveness (Phase 2)Study completedNCT03457701
What this trial is testing

Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)

Who this might be right for
Anaemia
GlaxoSmithKline 15
Testing effectiveness (Phase 2)Study completedNCT03799627
What this trial is testing

Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa

Who this might be right for
AnemiaDialysis-dependent Chronic Kidney Disease
Akebia Therapeutics 175
Testing effectiveness (Phase 2)Ended earlyNCT00453973
What this trial is testing

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Affymax 114
Large-scale testing (Phase 3)Study completedNCT02827266
What this trial is testing

Epoetin Beta (NeoRecormon) in Anemic Participants With Diabetes and Chronic Renal Failure Who Are Not on Dialysis

Who this might be right for
Anemia
Hoffmann-La Roche 122
Large-scale testing (Phase 3)Study completedNCT00598442
What this trial is testing

Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Affymax 493
Large-scale testing (Phase 3)Study completedNCT00642967
What this trial is testing

Subcutaneous Mircera for the Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis

Who this might be right for
Anemia
Hoffmann-La Roche 127
Large-scale testing (Phase 3)WithdrawnNCT05082571
What this trial is testing

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease

Who this might be right for
Anemia of Chronic Kidney Disease
Akebia Therapeutics
Testing effectiveness (Phase 2)Study completedNCT01630889
What this trial is testing

Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseEnd Stage Renal DiseaseAnemia
Kyntra Bio 15
Large-scale testing (Phase 3)WithdrawnNCT05082584
What this trial is testing

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents

Who this might be right for
Anemia of Chronic Kidney Disease
Akebia Therapeutics
Post-approval studies (Phase 4)Study completedNCT04059913
What this trial is testing

Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease

Who this might be right for
CKD Anemia in Dialysis Participants
Kyntra Bio 318
Large-scale testing (Phase 3)Study completedNCT02892149
What this trial is testing

Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD)

Who this might be right for
AnemiaDialysis-Dependent Chronic Kidney Disease
Akebia Therapeutics 3,554
Large-scale testing (Phase 3)Study completedNCT03409107
What this trial is testing

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)

Who this might be right for
Anaemia
GlaxoSmithKline 614
Large-scale testing (Phase 3)Ended earlyNCT00462384
What this trial is testing

Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Participants With Chronic Kidney Disease.

Who this might be right for
Anemia
Hoffmann-La Roche 39
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation